CytomX Therapeutics, Inc 10-K for FY2019
CytomX Therapeutics, Inc. (CTMX)
10-K
2020-02-27
For: 2019-12-31
View Original
Added on
April 09, 2026
About this 10-K
CytomX Therapeutics, Inc filed this 10-K on February 27, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $57.49M
- down 3.4% from $59.5M a year earlier
- Net loss
- $102.24M
- compared with a net loss of $84.6M a year earlier